Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  AbbVie Inc.    ABBV

ABBVIE INC.

(ABBV)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsPress ReleasesOfficial PublicationsSector newsMarketScreener StrategiesAnalyst Recommendations

AbbVie : Form 8.3 - -2-

share with twitter share with LinkedIn share with facebook
share via e-mail
01/17/2020 | 09:24am EST
----------------------------------------------------------- 
N/A 
----------------------------------------------------------- 
 
 
 
 
 
 
Is a Supplemental Form 8 attached? (Note 9)                      NO 
-------------------------------------------------------  ------------------- 
Date of disclosure                                       17(th) January 2020 
-------------------------------------------------------  ------------------- 
Contact name                                                Lionel Colaco 
-------------------------------------------------------  ------------------- 
Telephone number                                                020 33956098 
-------------------------------------------------------  ------------------- 
If a connected EFM, name of offeree/offeror with which   N/A 
 connected 
-------------------------------------------------------  ------------------- 
If a connected EFM, state nature of connection (Note     N/A 
 10) 
-------------------------------------------------------  ------------------- 
 
 
 
 
 
 

This article is part of a news chaine.
Article 2 / 2
<< Preceding Next >>
share with twitter share with LinkedIn share with facebook
share via e-mail
Latest news on ABBVIE INC.
02/21ABBVIE : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS..
AQ
02/21ABBVIE : Form 8.3 -
DJ
02/20ABBVIE : Declares Quarterly Dividend
PR
02/20ABBVIE : Form 8.3 - Abbvie Inc.
DJ
02/19ABBVIE : Form 8.3 - Abbvie Inc
DJ
02/19ABBVIE : to Present at the Cowen 40th Annual Health Care Conference
PR
02/18Monteverde & Associates PC Launches an Investigation of the Board of Director..
PR
02/18ABBVIE : Form 8.3 -
DJ
02/18Gilead's Coronavirus Drug Trial Slowed Due to Lack of Eligible Recruits
DJ
02/17ALLERGAN : Form 8.3 -
DJ
More news